COPD

A survey of patients with chronic obstructive pulmonary disease (COPD) who had contracted community-acquired pneumonia showed that the additional illness caused a significant burden, such as lost time from work, as well as a burden on their caregivers.

Six areas that need improvement emerged from a workshop examining best practices and models to reduce hospital readmissions in patients with chronic obstructive pulmonary disease (COPD).

A recent review showed that the long-term use of statins reduced the risk of acute exacerbation in chronic obstructive pulmonary disease (COPD), heart disease–related mortality and all-cause mortality, as well as decreased inflammatory factors.

Asthma–COPD overlap (ACO) is a term that encompasses patients with characteristics of 2 conditions, asthma and chronic obstructive pulmonary disease (COPD). A recent study from Spain sought to validate a proposed algorithm to help clinicians identify ACO among patients with COPD, in an effort to tailor treatment.

A phase 4 study of formoterol fumarate showed similar safety performance as placebo in patients with moderate-to-severe chronic obstructive pulmonary disease, according to a recently published study.

Researchers in the United Kingdom used a Markov microsimulation model comparing a population with chronic obstructive pulmonary disease (COPD) performing physical activity vs a COPD population that was sedentary, in order to estimate the cost-effectiveness of regular PA vs a sedentary lifestyle.

A recent study examined the nutritional status and dietary intake among outpatients with chronic obstructive pulmonary disease (COPD) and its possible associations with quality of life.

Researchers investigating the associations between ground-level ozone and fine particulate pollution and emergency department (ED) visits for chronic obstructive pulmonary disease, asthma, and respiratory infections found that as levels rose, more patients land in the ED with breathing problems.

Researchers said they found a previously unreported pathogenic entity that links chronic inflammation and tissue destruction in the lungs of patients with chronic obstructive pulmonary disease (COPD).

When to begin maintenance therapy for patients with chronic obstructive pulmonary disease (COPD) with either a single drug, or a combination of long-acting bronchodilators, is not always clear. A new study looking at whether baseline symptomatic status influences response to treatment suggests that patients with more severe dyspnea benefit more from a combination of tiotropium/olodaterol than tiotropium alone.

Chronic obstructive pulmonary disease is one of the world’s top drivers of chronic disease burdens, the chief executive officer of ResMed told the JP Morgan Healthcare Conference, as he explained the company’s strategy to help meet unmet needs using digital connectivity and data analytics.

A recent study looking at the impact of recent exacerbations of chronic obstructive pulmonary disease (COPD) on hospitalized patients who also have coronary artery disease (CAD) found that COPD was was independently associated with additional risks of complications after percutaneous coronary intervention.

Hospitalized patients with chronic obstructive pulmonary disease (COPD) who tested positive for the flu and were unvaccinated had worse death rates and more severe illness than those who were vaccinated, according to a recent study.

Long-term nicotine replacement therapy (LT-NRT) provides 1 way for smokers with chronic obstructive pulmonary disease (COPD) to try to quit, but does not result in greater rates of cessation or harm reduction, according to a recently published study.

Current guidelines for chronic obstructive pulmonary disease (COPD) call for using antibiotics in the emergency department (ED) when presented with acute exacerbations of COPD (AECOPD). A recent study sought to determine the rate at which patients with AECOPD are treated with antibiotics and also looked at the proportions of antibiotic classes prescribed, trends of antibiotic treatment, and identified independent predictors of antibiotic therapy.

Increased severity of chronic obstructive pulmonary disease (COPD) was associated with an increased risk of mortality and hospitalization in patients with heart failure, according to a recent study published in JAMA Open.

Patients hospitalized with exacerbations of chronic obstructive pulmonary disease (COPD) had worse impairments of cognition compared to those hospitalized without the disease, according to a recent study.

Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease, and patients can differ markedly in their rate of lung function decline and frequency of exacerbations. A recent study sought to determine what proportion of between-individual variability in symptoms can be explained by lung function versus all other observable characteristics.

A recent report, published by the Annals of the American Thoracic Society, assessed trends in chronic obstructive pulmonary disease (COPD) hospitalizations and in-hospital deaths in the United States and found that the number of in-hospital deaths for COPD has decreased; however, women account for a higher proportion of the hospitalizations and in-hospital deaths.

A recent study aimed to identify the characteristics of patients who demonstrate the greatest exacerbation risk reduction with roflumilast, finding that the medication is most successful in patients with prior hospitalization, greater exacerbation frequency, and higher baseline blood eosinophil count.

Propeller Health, a digital health company that makes sensors to track patient use of respiratory inhalers used for chronic obstructive pulmonary disease (COPD) and asthma, is being snapped up by ResMed, which makes connected devices for respiratory care.

Researchers investigated the association between chronic obstructive pulmonary disease (COPD) phenotypes and the prognosis of different histological subtypes of lung cancer and found that COPD, especially emphysema-predominant phenotype, was an independent prognostic risk factor for squamous carcinoma only.

By meeting challenges in caring for patients with chronic obstructive pulmonary dieases head-on, primary care doctors have an opportunity to reduce the potential for unnecessary or sub-optimal care while improving patient outcomes.

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in the United States, and for COPD Awareness Month this November, The American Journal of Managed Care® conducted a Q&A with Jamie Sullivan, MPH, vice president of public policy and outcomes for The COPD Foundation, as well as Chief Medical Officer Byron M. Thomashow, MD. The COPD Foundation is a not-for-profit organization that works to improve the lives of patients with COPD.

Recent research indicates that there are age-associated gender differences seen in the disease burden of chronic obstructive pulmonary disorder (COPD), with younger women more severely affected.